CTLA4 and cancer: Immunotherapy has taken a prominent role in the treatment of a number of cancer indications.1 2 Recent clinical successes using antibody blockade of immune checkpoint inhibitory receptors expressed on T cells such as CTLA4 or PD-(L)1 have transformed the treatment options for some patients with cancer.